OHPAS drug-linker platform | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

51,587 results for “OHPAS drug-linker platform”

Trials

View all 23029 →

Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy

30 participants · First posted Sep 19, 2024

Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform

1,000 participants · First posted Jul 27, 2022

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

10,000 participants · First posted Feb 22, 2019

Drugs

View all 1162 →

Quaternary amine linker antibody-drug conjugates(Seattle Genetics)

Microbiome Platform

Gut'Innov platform(Da Volterra)

Organizations

View all 412 →

European Thoracic Oncology Platform

Switzerland

Redpharm Drug

United States

Chain Drug Consortium

United States

News

View all 26984 →

Xcellon Biologics Expands ADC Development Capabilities Through Strategic Partnerships with Invenra and IntoCell

WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Platform to Ona Therapeutics for First-in-Class ADC

Carbogen Amcis Secures CHF 25+ Million Co-Investment to Expand ADC Drug Linker Manufacturing in Switzerland

Page 1 of 5159